Vanguard Group Inc Krystal Biotech, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,792,208 shares of KRYS stock, worth $576 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,792,208
Previous 2,822,888 1.09%
Holding current value
$576 Million
Previous $388 Million 27.03%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$134.94 - $176.75 $4.14 Million - $5.42 Million
-30,680 Reduced 1.09%
2,792,208 $493 Million
Q2 2025

Aug 11, 2025
SELL
$123.36 - $181.0 $295,323 - $433,314
-2,394 Reduced 0.08%
2,822,888 $388 Million
Q1 2025

May 09, 2025
SELL
$142.64 - $194.44 $7.58 Million - $10.3 Million
-53,169 Reduced 1.85%
2,825,282 $509 Million
Q4 2024

Feb 11, 2025
BUY
$156.64 - $199.61 $4.5 Million - $5.73 Million
28,707 Added 1.01%
2,878,451 $451 Million
Q3 2024

Nov 13, 2024
SELL
$174.7 - $213.66 $3.39 Million - $4.14 Million
-19,392 Reduced 0.68%
2,849,744 $518 Million
Q2 2024

Aug 13, 2024
BUY
$153.12 - $183.64 $66.8 Million - $80.1 Million
436,357 Added 17.94%
2,869,136 $527 Million
Q1 2024

May 10, 2024
SELL
$108.01 - $179.35 $323,489 - $537,153
-2,995 Reduced 0.12%
2,432,779 $433 Million
Q4 2023

Feb 14, 2024
BUY
$96.0 - $128.29 $3.42 Million - $4.57 Million
35,632 Added 1.48%
2,435,774 $302 Million
Q3 2023

Nov 14, 2023
BUY
$108.51 - $130.22 $75.3 Million - $90.4 Million
693,852 Added 40.66%
2,400,142 $278 Million
Q2 2023

Aug 14, 2023
BUY
$78.48 - $130.32 $39.6 Million - $65.7 Million
504,060 Added 41.93%
1,706,290 $200 Million
Q1 2023

May 15, 2023
BUY
$72.39 - $84.27 $1.02 Million - $1.19 Million
14,120 Added 1.19%
1,202,230 $96.3 Million
Q4 2022

Feb 10, 2023
BUY
$63.14 - $79.9 $5.81 Million - $7.35 Million
91,978 Added 8.39%
1,188,110 $94.1 Million
Q3 2022

Nov 14, 2022
BUY
$64.85 - $82.4 $1.74 Million - $2.21 Million
26,844 Added 2.51%
1,096,132 $76.4 Million
Q2 2022

Aug 12, 2022
BUY
$48.93 - $73.47 $873,057 - $1.31 Million
17,843 Added 1.7%
1,069,288 $70.2 Million
Q1 2022

May 13, 2022
BUY
$51.99 - $72.11 $1.45 Million - $2.01 Million
27,835 Added 2.72%
1,051,445 $70 Million
Q4 2021

Feb 14, 2022
BUY
$39.81 - $88.24 $5.37 Million - $11.9 Million
134,952 Added 15.19%
1,023,610 $71.6 Million
Q3 2021

Nov 12, 2021
BUY
$52.01 - $71.77 $2.2 Million - $3.04 Million
42,303 Added 5.0%
888,658 $46.4 Million
Q2 2021

Aug 13, 2021
BUY
$62.14 - $81.82 $52.6 Million - $69.2 Million
846,355 New
846,355 $57.6 Million

Others Institutions Holding KRYS

# of Institutions
325
Shares Held
25M
Call Options Held
241K
Put Options Held
625K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $5.29B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email